(Q33900810)

29 July 2017

1 reference

title

Epidemiology of HIV infection in the newborn (English)

1 reference

29 July 2017

main subject

epidemiology of HIV/AIDS

1 reference

2

1 reference

29 July 2017

Thorne C

1

1 reference

29 July 2017

language of work or name

1 reference

1 April 2000

1 reference

29 July 2017

published in

Early Human Development

1 reference

29 July 2017

volume

58

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

1-16

1 reference

HIV prevalence in pregnant women in Europe: differences in assessment methods and prevalence levels across countries

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Trends in HIV prevalence among childbearing women in the United States, 1989-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Heterosexual behavior during pregnancy and perinatal transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Mechanisms and timing of mother-to-child transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Postnatal transmission of HIV-1 associated with breast abscess

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Risk of human immunodeficiency virus type 1 transmission through breastfeeding

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Maternal viral load, CD4 cell count and vertical transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Vertical HIV-1 transmission correlates with a high maternal viral load at delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Vitamin A deficiency and maternal-infant transmission of HIV in two metropolitan areas in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Maternal vitamin A deficiency and mother-to-child transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Human Immunodeficiency Virus Type 1-Infected Cells in Breast Milk: Association with Immunosuppression and Vitamin A Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Perinatal Transmission of the Human Immunodeficiency Virus Type 1 to Infants of Seropositive Women in Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Mode of delivery and gestational age influence perinatal HIV-1 transmission. Italian Register for HIV Infection in Children.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Breastfeeding, genetic, obstetric and other risk factors associated with mother-to-child transmission of HIV-1 in Sao Paulo State, Brazil. Sao Paulo Collaborative Study for Vertical Transmission of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. South African Vitamin A Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Is zidovudine therapy in pregnant HIV-infected women associated with gestational age and birthweight?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Incidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers. The Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Human T-cell lymphotropic virus type III (HTLV-III) embryopathy. A new dysmorphic syndrome associated with intrauterine HTLV-III infection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Perinatal findings in children born to HIV-infected mothers. The European Collaborative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Progression of human immunodeficiency virus disease among infants and children infected perinatally with human immunodeficiency virus or through neonatal blood transfusion. Los Angeles County Pediatric AIDS Consortium and the Los Angeles County-Univ

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Prospective study of human immunodeficiency virus 1-related disease among 512 infants born to infected women in New York City. The New York City Perinatal HIV Transmission Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Swiss Neonatal HIV Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Risk factors for mother-to-child transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Prevention of vertical HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Tran

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

HIV transmission through breastfeeding: a study in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Breastfeeding by HIV-1-infected women and outcome in their infants: a cohort study from Durban, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Maternal serum vitamin A levels are not associated with mother-to-child transmission of HIV-1 in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. The European Collaborative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Changes in use of antiretroviral therapy in regions of Europe over time

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Rapid change in the use of antiretroviral agents and improvement in a population of HIV-infected patients: France, 1995-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Profound anemia in a newborn infant of a mother receiving antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Zidovudine-associated embryonic toxicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Severe paronychia due to zidovudine-induced neutropenia in a neonate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2800%2900049-9

7 January 2021

10.1016/S0378-3782(00)00049-9

Identifiers

DOI

1 reference

29 July 2017

1 reference